TEVA - Teva Pharmaceuticals

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, May 10, 2016.

  1. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    There won't be enough time to react tomorrow morning with shorts covering, funds buying back, new longs piling in, lol!
     
    Jack Levy and Charles Noble like this.
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    FINALLY!

    This has been going down forever!

    Getting some actiont his morning.
     
  3. SammyN

    SammyN New Member

    Joined:
    Nov 6, 2016
    Messages:
    18
    Likes Received:
    3
    Worth picking up some shares now at this price?
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    I dont like chasing, but if you wait for a pullback...
     
    SammyN likes this.
  5. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    almost 20 in pre-market. shares trading super positive
     
  6. MiguelHammond10

    Joined:
    Jun 12, 2017
    Messages:
    92
    Likes Received:
    5
    This goes back to $25-$30 range by year end. As always, sad I didn't buy more at the bottom, but was 45,000 shares deep in this :/
     
  7. Jack Levy

    Jack Levy Well-Known Member

    Joined:
    Jun 6, 2017
    Messages:
    215
    Likes Received:
    316
    I will bet it rebound on the future. As the Chinese proverb says: 'A starved camel is still bigger than a horse'
     
    Charles Noble and fidelgeorge like this.
  8. Jonathan Wiley

    Joined:
    Jun 13, 2017
    Messages:
    46
    Likes Received:
    7
    Generic medicines gross profit declined 27% compared with the year-earlier period, the company said, and specialty medicines revenue slumped 1% compared with the year-earlier period, including a 7% decline in revenue for Teva's popular multiple sclerosis drug Copaxone, which is now facing generic competition.
     
  9. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    Too many people constantly flipping between short and long, no balls or commitment to either. Teva will shake all these amateurs out.
     
    Jack Levy and Charles Noble like this.
  10. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    TEVA alert!

    Pre market action!
     
  11. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Off that $15 support, TEVA making some comeback attempts
     
  12. Melissa

    Melissa Member

    Joined:
    Jun 19, 2017
    Messages:
    43
    Likes Received:
    15
    Don't be so skeptical. ;)I think TEVA has chances to get $20 next week.
     
  13. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
    StockJock-e likes this.
  14. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    More upside here today

    American depositary receipts of Teva Pharmaceutical Industries Ltd. (TEVA) rose 6.6% after Berkshire Hathaway disclosed an investment in the drugmaker. A filing from Berkshire showed that the company had purchased 18.9 million Teva shares worth a total of $357.695 million in last year's fourth quarter.
     
  15. Melissa

    Melissa Member

    Joined:
    Jun 19, 2017
    Messages:
    43
    Likes Received:
    15
    That's it! TEVA got finally $20.
     
  16. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    34
    The generic market is highly crowded and Teva faces competition from players like Mylan, Dr. Reddy’s, and Sandoz among others.

    Competition is fierce as generic companies strive to be the first to launch a generic version once a brand product loses exclusivity so that they can capture significant market share. Once additional generic companies enter the market, market share, revenues and gross profit typically decline.
     
  17. HumbleInvestor

    HumbleInvestor New Member

    Joined:
    Apr 16, 2018
    Messages:
    19
    Likes Received:
    3
    TEVA is a good company, this will make it become better.
     
  18. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    34
    Copaxone and Austedo sales are exceeding analysts' expectations. Also, the company's cost-saving efforts are noticeable.

    The management estimates it can still launch chronic migraine drug fremanezumab by year-end following potential near-term resolution of regulatory issues at API manufacturer Celltrion.
     
  19. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    This sell off is hitting a support level I had set an alert for.

    Anybody else looking to go long soon?
     
  20. spooks

    spooks New Member

    Joined:
    Jan 10, 2017
    Messages:
    29
    Likes Received:
    1
    The stock is going down... not sure this is the moment to buy. Perhaps wait a bit more.

    Good news, but the stock is down >8% !
    Why?
    I have not been following it, but just noticed it.
     

Share This Page